About Acton Pharmaceuticals
Acton Pharmaceuticals is a Healthcare company based in Marlborough (United States) founded in 2008, and was acquired by Meda in August 2013. Generic drugs for respiratory disorders are manufactured and commercialized. Acton Pharmaceuticals has raised $36.7 million across 4 funding rounds from investors including Sequoia Capital and Mylan. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.
Company details
Acton Pharmaceuticals was established in 2008 in Marlborough, United States, within the pharmaceuticals sector. Focus is placed on developing and commercializing products for respiratory conditions, including generic drugs. Operations center on treatment solutions for such disorders. Acquisition by Meda Pharmaceuticals occurred on August 30, 2013, integrating its activities into the larger entity.
- Headquarters Marlborough, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website actonpharmaceuticals.com
- Social LinkedIn
- Acquired by Meda (Aug 2013)
- Total Equity Funding$36.7M (USD)
in 4 rounds
- Latest Funding Round$7M (USD), Series B
May 2013
- InvestorsSequoia Capital
& 1 more
- Acquired byMeda
(Aug 2013)
Funding Insights of Acton Pharmaceuticals
Acton Pharmaceuticals has successfully raised a total of $36.7M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.7M
- Total Rounds 4
- Last Round Series B — $7M
- First Round $500,000
(Dec 2009)
- Investors Count 1
All 4 funding rounds of Acton Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $7M | Series B | – | – | – |
| Sep 2010 | $14.2M | Series A | – | – | – |
| Jan 2010 | $15M | Series A | – | – | |
| Dec 2009 | $500,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Acton Pharmaceuticals
Acton Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Sequoia Capital and Mylan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Mylan, part of Viatris, is focused on healthcare solutions. | meda.se |
Investor details for Acton Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Acton Pharmaceuticals
4 dated milestones of Acton Pharmaceuticals across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Acton Pharmaceuticals is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series B, of $7.0M.
- Exit Acquired by Meda.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Acton Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acton Pharmaceuticals
Acton Pharmaceuticals was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Acton Pharmaceuticals is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Acton Pharmaceuticals is a funded company, having raised a total of $36.7M across 4 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Dec 2009.
Acton Pharmaceuticals was established in 2008 in Marlborough, United States, within the pharmaceuticals sector. Focus is placed on developing and commercializing products for respiratory conditions, including generic drugs. Operations center on treatment solutions for such disorders. Acquisition by Meda Pharmaceuticals occurred on August 30, 2013, integrating its activities into the larger entity.
Acton Pharmaceuticals has 2 investors. Key investors include Sequoia Capital, and Mylan.
Yes. Acton Pharmaceuticals was acquired by Meda in August 2013.